accountPfizer Inc. and Bristol-Myers Squibb Co. will release late-stage study results for the potential blockbuster blood thinner apixaban Tuesday at the European Society of Cardiology Congress 2010. The New York drugmakers...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer, Bristol-Myers to present drug data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account